By activating AMPK, metformin inhibits the mammalian target of rapamycin (mTOR) pathway, which is critical for cell growth and proliferation, thereby reducing protein synthesis and suppressing cancer cell growth [12]. The gene discussed is MTOR; the disease is cancer.